Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Affinivax is a company in biotechnology, health care, medical, pharmaceutical based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2014.
Its activity falls under biotechnology, health care, medical, pharmaceutical; the profile below is assembled from public directory data.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
Its current recorded stage is Grant.
The company reports a headcount in the c_00051_00100 range.
Total disclosed funding stands at about $377.5M.
| Sector | Biotechnology, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Country | US |
| Founded | 2014 |
| Employees | c_00051_00100 |
| Stage | grant |
| Total funding | $377,487,455 |
Website: www.affinivax.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account